BCX 4430 3022 Epetraborole was in development for

Epetraborole was in development for the treatment of infections caused by multidrug-resistant Gram-negative pathogens

19992-50-8

Formula: C8H14ClNO2

RS-127445 is found to have nM affinity and 1000 fold selectivity for the 5-HT2B receptor

Osteoporos Int

BCX 4430 3022 Epetraborole was in development forGalidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,